1. Pai, Govind, Roohollahi, Khashayar, Rockx, Davy, Wolthuis, Rob M F, Dorsman, Josephine C. 2023. Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma. In Communications biology, 6, 37. doi:10.1038/s42003-022-04389-3. https://pubmed.ncbi.nlm.nih.gov/36639418/
2. Lim, Seakcheng, Shparberg, Rachel A, Coorssen, Jens R, O'Connor, Michael D. 2020. Application of the RBBP9 Serine Hydrolase Inhibitor, ML114, Decouples Human Pluripotent Stem Cell Proliferation and Differentiation. In International journal of molecular sciences, 21, . doi:10.3390/ijms21238983. https://pubmed.ncbi.nlm.nih.gov/33256189/
3. O'Connor, Michael D, Wederell, Elizabeth, Robertson, Gordon, Aparicio, Samuel A J R, Eaves, Connie J. 2011. Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance. In Experimental hematology, 39, 866-79.e1. doi:10.1016/j.exphem.2011.05.008. https://pubmed.ncbi.nlm.nih.gov/21689726/
4. Nachmany, Henny, Wald, Shane, Abekasis, Michal, Bulvik, Shlomo, Weil, Miguel. . Two potential biomarkers identified in mesenchymal stem cells and leukocytes of patients with sporadic amyotrophic lateral sclerosis. In Disease markers, 32, 211-20. doi:10.3233/DMA-2011-0885. https://pubmed.ncbi.nlm.nih.gov/22430187/
5. Tang, Shan, Beattie, Adam T, Kafkova, Lucie, Freeman, Matthew, Chin, Jason W. 2022. Mechanism-based traps enable protease and hydrolase substrate discovery. In Nature, 602, 701-707. doi:10.1038/s41586-022-04414-9. https://pubmed.ncbi.nlm.nih.gov/35173328/
智鼠故事 
